Compile Data Set for Download or QSAR
Report error Found 75 Enz. Inhib. hit(s) with all data for entry = 9531
TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237517(CHEMBL4078268 | US10836758, Example 20)
Affinity DataIC50: 7nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472970(US10836758, Example 59)
Affinity DataIC50: 8nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472965(55 | US10836758, Example 54)
Affinity DataIC50: 9nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237522(CHEMBL4060154 | US10836758, Example 17)
Affinity DataIC50: 9nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472962(US10836758, Example 51)
Affinity DataIC50: 10nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237518(CHEMBL4076444 | US10836758, Example 4)
Affinity DataIC50: 10nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237526(CHEMBL4092078 | US10836758, Example 12)
Affinity DataIC50: 11nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237525(CHEMBL4078252 | US10836758, Example 2)
Affinity DataIC50: 12nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472942(US10836758, Example 31)
Affinity DataIC50: 12nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472941(US10836758, Example /30)
Affinity DataIC50: 12nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237516(CHEMBL4080712 | US10836758, Example 18)
Affinity DataIC50: 14nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472960(50 | US10836758, Example 49)
Affinity DataIC50: 15nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472934(US10836758, Example 23)
Affinity DataIC50: 16nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237499(CHEMBL4076627 | US10836758, Example 19)
Affinity DataIC50: 16nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237508(CHEMBL4071098 | US10836758, Example 13)
Affinity DataIC50: 17nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237520(CHEMBL4088581 | US10836758, Example 3)
Affinity DataIC50: 21nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472939(US10836758, Example 28)
Affinity DataIC50: 27nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472937(US10836758, Example 26)
Affinity DataIC50: 27nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472943(US10836758, Example 32)
Affinity DataIC50: 28nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237509(CHEMBL4103940 | US10836758, Example 16)
Affinity DataIC50: 29nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472958(US10836758, Example 47)
Affinity DataIC50: 33nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261096(CHEMBL4075332 | US10836758, Example 73)
Affinity DataIC50: 37nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472956(US10836758, Example 45)
Affinity DataIC50: 39nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472938(US10836758, Example 27)
Affinity DataIC50: 40nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472986(US10836758, Example 75)
Affinity DataIC50: 41nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237532(CHEMBL4096299 | US10836758, Example 1)
Affinity DataIC50: 42nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472936(US10836758, Example 25)
Affinity DataIC50: 50nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261088(CHEMBL4094490 | US10836758, Example 72)
Affinity DataIC50: 50nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472972(62 | US10836758, Example 61)
Affinity DataIC50: 52nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472973(US10836758, Example 62)
Affinity DataIC50: 55nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472933(US10836758, Example 22)
Affinity DataIC50: 61nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472920(US10836758, Example 9)
Affinity DataIC50: 62nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472963(US10836758, Example 52)
Affinity DataIC50: 64nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237514(CHEMBL4089010 | US10836758, Example 6)
Affinity DataIC50: 67nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472974(US10836758, Example 63)
Affinity DataIC50: 68nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472935(US10836758, Example 24)
Affinity DataIC50: 69nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237512(CHEMBL4091922 | US10836758, Example 5)
Affinity DataIC50: 70nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261075(CHEMBL4087220 | US10836758, Example 7)
Affinity DataIC50: 74nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472940(US10836758, Example 29)
Affinity DataIC50: 74nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472967(57 | US10836758, Example 56)
Affinity DataIC50: 78nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472976(US10836758, Example 65)
Affinity DataIC50: 98nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472946(US10836758, Example 35)
Affinity DataIC50: 101nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472964(US10836758, Example 53)
Affinity DataIC50: 105nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472952(US10836758, Example 41)
Affinity DataIC50: 108nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472957(US10836758, Example 46)
Affinity DataIC50: 110nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM472959(US10836758, Example 48)
Affinity DataIC50: 117nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261129(CHEMBL4064762 | US10836758, Example 71)
Affinity DataIC50: 120nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50237504(CHEMBL4067455 | US10836758, Example 44)
Affinity DataIC50: 124nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261137(CHEMBL4102647 | US10836758, Example 11)
Affinity DataIC50: 127nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

TargetSodium channel protein type 9 subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM50261122(CHEMBL4073353 | US10836758, Example 37)
Affinity DataIC50: 133nMAssay Description:hNaV1.7 binding affinities were determined with a filtration binding assay using purified membranes from HEK293 cells stably expressing hNaV1.7. HEK2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
US Patent

Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: